Adocia S.A.

Adocia S.A.

ADOIF - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$103.66M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Adocia S.A.Adocia S.A.-5.8-547%--1.8

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$103.66 Million
Enterprise Value$102.33 Million
Earnings per Share$-3.22
Beta0.72
Outstanding Shares-

Return

Return on Equity546.67%ROE
Return on Assets-117.00%
Return on Invested Capital-607.78%

Valuation & Multiples

P/E Ratio-5.77P/E Ratio
PEG-939.35PEG
Price to Sales-Price to Sales
Price to Book Ratio-Price to Book Ratio
Enterprise Value to Revenue10.96
Enterprise Value to EBIT-7.88
Enterprise Value to Net Income-5
Total Debt to Enterprise0.08
Debt to Equity-1.84Debt to Equity

Revenue Sources

No data

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Adocia S.A.

80 employees
CEO: Olivier Soula

Adocia S.A. is a clinical-stage biotechnology firm that specializes in developing enhanced formulations of existing therapeutic proteins and peptides, primarily targeting diabetes and other metabolic disorders. The company leverages its ...